Teva to collaborate with Fosun Pharma for TEV-56278
The collaboration will enhance clinical data generation for the potential treatment.
Healthcare
EHA 2025: AstraZeneca’s surovatamig is potential next-gen BiTE for R/R B-ALL
NICE approves GSK’s belantamab mafodotin for blood cancer
Antares Therapeutics gains $177m for cancer medicines development
Caribou cuts pipeline and workforce to focus on lead CAR-T programmes
European agencies catch up with speedier regulatory pathways for CGTs in the US
Inborn errors of metabolism elicit unique challenges for therapy development
EU reshapes HTAs: is the industry ready for it?
